PharmaCongress: Agenda: Day 1

Pre-Conference/
Day One

Day Two

Day Three

Agenda: Day 2 Thursday, November 14, 2002
8:00 a.m.	Welcome and Introductions Valli Baldassano Senior Director Global Compliance Associate General Counsel, Pharmacia Peapack, NJ (Conference Co chair)
8:15 a.m.	Corporate Responsibility in the Pharmaceutical Industry Fred Hassan Chairman and Chief Executive Officer Pharmacia Corporation Chairman, Pharmaceutical Research & Manufacturers of America (PhRMA) Peapack, NJ
9:00 a.m.	Compliance Officer Roundtable: Best Practices Exchange Valli Baldassano, Esq. Senior Director Global Compliance and Associate General Counsel Pharmacia Corporation Bedminster, NJ Douglas Lankler, Esq. Corporate Counsel Corporate Compliance Pfizer Inc New York, NY Arjun Rajaratnam, Esq. Compliance Officer Global Pharmaceuticals GlaxoSmithKline Research Triangle Park, NC Bert Weinstein, Esq. Vice President and Assistant General Counsel Merck & Co., Inc. Whitehouse Station, NJ Brent Saunders, JD, MBA Partner, PricewaterhouseCoopers, LLP Florham Park, NJ (Moderator)
10:15 a.m.	Break
10:45 a.m.	Concurrent Session I
	1.01 Perspective on Pharmaceutical Sales and Marketing Practices Michael Loucks, Esq. Chief of the Health Care Fraud Unit Assistant U.S. Attorney U.S. Attorney's Office for the District of Massachusetts Boston, MA
	1.02 Compliance Reporting and Auditing: Best Practice Exchange Peter Claude Senior Manager PricewaterhouseCoopers LLP Anthony Farino Partner PricewaterhouseCoopers, LLP Chicago, IL Presentation Material (Acrobat) Presentation Material (Powerpoint)
	1.03 Compliance Issues and Strategies for Clinical Research Seth Whitelaw Compliance Officer Global R&D GlaxoSmithKline Philadelphia, PA Presentation Material A (Acrobat) Presentation Material A (Powerpoint) Presentation Material B (Acrobat) Presentation Material C (Acrobat) Presentation Material C (Microsoft Word) Heather Stewart, Esq. Senior Associate Porter Wright Morris & Arthur, LLP Washington, DC Presentation Material (Acrobat) Presentation Material (Powerpoint)
	1.04 Part 11 Compliance and other Related Issues - A Panel Discussion Ron Lee Director, 21 CFR Part 11/Annex 11 Program Office Chiron San Francisco, CA Robert Steinmeier 21 CFR Part 11 Program Manager Abbott Laboratories Abbott Park, IL Peter Tarasov AstraZeneca Patrick A. Roche Senior Manager Global Risk Management Solutions PricewaterhouseCoopers, LLP Florham Park, NJ (Moderator) Presentation Material (Acrobat) Presentation Material (Powerpoint)
	1.05 Negotiating Fraud Settlements Stuart Kurlander, Esq. Partner Latham & Watkins Washington, DC Presentation Material (Acrobat) Presentation Material (Powerpoint)
Noon	Lunch
12:30 p.m.	Introductory Comments Douglas Lankler, Esq. Corporate Counsel, Compliance Pfizer, Inc. New York, NY (Conference Co chair)
12:45 p.m.	Lunch Keynote Speaker Uwe E. Reinhardt, Ph.D. James Madison Professor of Political Economy Woodrow Wilson School Princeton University Princeton, NJ
1:30 p.m.	Lunch Presentation: The New Role of Corporate Ethics Jacqueline Brevard, Esq. Chief Ethics Officer Merck & Co. Whitehouse Station, NJ Diane Nobles Senior Vice President for Compliance and Integrity Caremark Rx Chicago, IL Brenda Hildreth Manager, Business Practices Baxter International Inc. Deerfield, IL Steve Priest President Ethical Leadership Group Chicago, IL (Moderator)
2:30 p.m.	Break
2:45 p.m.	Concurrent Sessions II
	2.01 When Pharmaceutical Marketing Crosses the Line: Best Practices for Investigation and Remediation Edward R. Malone, Esq. Jenner & Block, LLC Chicago, IL Mark A. Pollack, Esq. Partner Jenner & Block, LLC Chicago, IL Presentation Material (Acrobat) Presentation Material (Powerpoint) Presentation Material (Acrobat) Presentation Material (Microsoft Word)
	2.02 Compliance Program Effectiveness - Is Your Compliance Program Where it Should Be? Eve Costopoulos, Esq. Senior Legal Director Compliance Schering-Plough Corporation Kenilworth, NJ Presentation Material (Acrobat) Presentation Material (Powerpoint)
	2.03 Corporate Compliance vs. Enterprise Wide Risk Management Brent Saunders, JD, MBA Partner, PricewaterhouseCoopers, LLP Founder and 1st VP International Association of Privacy Officers Past President Health Care Compliance Association Florham Park, NJ Presentation Material (Acrobat) Presentation Material (Powerpoint)
	2.04 Hot Topics: OIG Model Guidance, Recent Issues and More... John Bentivoglio, Esq. Partner, Arnold & Porter Former Special Counsel for Health Care Fraud Chief Privacy Officer, Department of Justice Washington, DC Presentation Material (Acrobat) Presentation Material (Powerpoint)
	2.05 Clinical Research Compliance: Human Subject Protections Tom Puglisi, Ph.D. Clinical Research Consulting Team PricewaterhouseCoopers, LLP Former Director of Human Subject Protections for the Office for Human Research Protections Department of Health and Human Services Washington, DC Presentation Material (Acrobat) Presentation Material (Powerpoint)
4:00 p.m.	Break
4:15 p.m.	What the Election Results Will Mean For Health Care Gail R. Wilensky, Ph.D. John M. Olin Senior Fellow, Project HOPE Co-Chair, President's Task Force to Improve Health Care Delivery for Our Nation's Veterans Former Administrator, Health Care Financing Administration (HCFA) Former Chair Medicare Payment Advisory Commission And Physician Payment Review Commission Washington, DC Presentation Material (Acrobat) Presentation Material (Powerpoint)
5:15 p.m.	Adjournment and Networking Reception

top of page